Ashok Leyland’s (AL) 1QFY21 performance was supported by non-vehicle revenue, leading to better mix. While M&HCV recovery is expected only in 2HFY21, expansion in LCVs should reduce the pain. Net debt has inched up but should reduce in 2HFY21.
OutlookWe expect gradual recovery from 2HFY21, and hence, have tweaked our estimates. Maintain Buy with TP of INR72 (~10x Sep’22E EV/EBITDA + INR8.5/share for HLFL).
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.